Antihyperlipidemic agents prior authorization and quantity limits
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Massachusetts Policy 013 alerts
Get alerted when Policy 013 changes without checking for updates manually.
Monitor payer policy activity
Governs prior authorization, quantity limit, and formulary requirements for select antihyperlipidemic medications for BCBSMA commercial members; affects providers submitting pharmacy or medical benefit requests.
Addition of Tryngolza to the policy.
Updated removal of trial of three statins requirement for Praluent and Repatha.
Updated to add Repatha indication previously (historic note).
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.